These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 8693373)

  • 1. Apolipoprotein B levels and related factors in a rural white South African community--the CORIS study. Coronary Risk Factor Study.
    Steyn K; Rossouw JE; Weight MJ; Fourie JM; Benadé AJ; Jooste PL; Chalton DO; Wolmarans P
    S Afr Med J; 1996 Apr; 86(4):359-64. PubMed ID: 8693373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum triglyceride, high-density lipoprotein cholesterol, apolipoprotein B, and coronary heart disease in a Chinese population undergoing coronary angiography.
    Ling Y; Jiang J; Wu B; Gao X
    J Clin Lipidol; 2017; 11(3):646-656. PubMed ID: 28506386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of Lp[a] and other independent risk factors for CHD in Asian Indians and their USA counterparts.
    Hoogeveen RC; Gambhir JK; Gambhir DS; Kimball KT; Ghazzaly K; Gaubatz JW; Vaduganathan M; Rao RS; Koschinsky M; Morrisett JD
    J Lipid Res; 2001 Apr; 42(4):631-8. PubMed ID: 11290835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apolipoprotein B and coronary artery disease in women: a cross-sectional study in women undergoing their first coronary angiography.
    Westerveld HT; van Lennep JE; van Lennep HW; Liem AH; de Boo JA; van der Schouw YT; Erkelens DW
    Arterioscler Thromb Vasc Biol; 1998 Jul; 18(7):1101-7. PubMed ID: 9672070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of apolipoprotein B to cholesterol in low density lipoproteins of patients with coronary heart disease.
    Vega GL; Grundy SM
    J Lipid Res; 1984 Jun; 25(6):580-92. PubMed ID: 6747462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Triglyceride-Lowering LPL Variants and LDL-C-Lowering LDLR Variants With Risk of Coronary Heart Disease.
    Ference BA; Kastelein JJP; Ray KK; Ginsberg HN; Chapman MJ; Packard CJ; Laufs U; Oliver-Williams C; Wood AM; Butterworth AS; Di Angelantonio E; Danesh J; Nicholls SJ; Bhatt DL; Sabatine MS; Catapano AL
    JAMA; 2019 Jan; 321(4):364-373. PubMed ID: 30694319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-high-density lipoprotein cholesterol and apolipoprotein B in the prediction of coronary heart disease in men.
    Pischon T; Girman CJ; Sacks FM; Rifai N; Stampfer MJ; Rimm EB
    Circulation; 2005 Nov; 112(22):3375-83. PubMed ID: 16316964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipid profile status and other related factors in patients with Hyperphenylalaninaemia.
    Couce ML; Vitoria I; Aldámiz-Echevarría L; Fernández-Marmiesse A; Roca I; Llarena M; Sánchez-Pintos P; Leis R; Hermida A
    Orphanet J Rare Dis; 2016 Sep; 11(1):123. PubMed ID: 27612877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of age, gender, and menopausal status on plasma low density lipoprotein cholesterol and apolipoprotein B levels in the Framingham Offspring Study.
    Schaefer EJ; Lamon-Fava S; Cohn SD; Schaefer MM; Ordovas JM; Castelli WP; Wilson PW
    J Lipid Res; 1994 May; 35(5):779-92. PubMed ID: 8071601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The lipid and lipoprotein profile of the urban black South Africa population of the Cape Peninsula - the BRISK study.
    Oelofse A; Jooste PL; Steyn K; Badenhorst CJ; Lombard C; Bourne L; Fourie J
    S Afr Med J; 1996 Feb; 86(2):162-6. PubMed ID: 8619144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concentration of apolipoprotein B is comparable with the apolipoprotein B/apolipoprotein A-I ratio and better than routine clinical lipid measurements in predicting coronary heart disease mortality: findings from a multi-ethnic US population.
    Sierra-Johnson J; Fisher RM; Romero-Corral A; Somers VK; Lopez-Jimenez F; Ohrvik J; Walldius G; Hellenius ML; Hamsten A
    Eur Heart J; 2009 Mar; 30(6):710-7. PubMed ID: 18676970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The conjoint trait of low high-density lipoprotein cholesterol and high triglycerides in adolescent black and white males.
    Morrison JA; Barton BA; Biro FM; Sprecher DL
    Metabolism; 1998 May; 47(5):514-21. PubMed ID: 9591740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Residual dyslipidemia according to low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B among statin-treated US adults: National Health and Nutrition Examination Survey 2009-2010.
    Wong ND; Chuang J; Zhao Y; Rosenblit PD
    J Clin Lipidol; 2015; 9(4):525-32. PubMed ID: 26228670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statin therapy alters the relationship between apolipoprotein B and low-density lipoprotein cholesterol and non-high-density lipoprotein cholesterol targets in high-risk patients: the MERCURY II (Measuring Effective Reductions in Cholesterol Using Rosuvastatin) trial.
    Ballantyne CM; Raichlen JS; Cain VA
    J Am Coll Cardiol; 2008 Aug; 52(8):626-32. PubMed ID: 18702965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apolipoprotein C-III, a strong discriminant of coronary risk in men and a determinant of the metabolic syndrome in both genders.
    Onat A; Hergenç G; Sansoy V; Fobker M; Ceyhan K; Toprak S; Assmann G
    Atherosclerosis; 2003 May; 168(1):81-9. PubMed ID: 12732390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apolipoprotein B, ratio of total cholesterol to HDL-C, and blood pressure in abdominally obese white and black American women.
    Okosun IS; Choi S; Hash R; Dever GE
    J Hum Hypertens; 2001 May; 15(5):299-305. PubMed ID: 11378831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apolipoprotein B and non-high density lipoprotein cholesterol and the risk of coronary heart disease in Chinese.
    Chien KL; Hsu HC; Su TC; Chen MF; Lee YT; Hu FB
    J Lipid Res; 2007 Nov; 48(11):2499-505. PubMed ID: 17698856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonfasting apolipoprotein B and triglyceride levels as a useful predictor of coronary heart disease risk in middle-aged UK men.
    Talmud PJ; Hawe E; Miller GJ; Humphries SE
    Arterioscler Thromb Vasc Biol; 2002 Nov; 22(11):1918-23. PubMed ID: 12426225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relation of family history and reversible risk factors to coronary heart disease prevalence in an Afrikaner community.
    Rossouw JE; Thompson ML; Jooste PL; Swanepoel AS; Jordaan PC
    Arterioscler Thromb; 1991; 11(1):130-7. PubMed ID: 1987990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rare Protein-Truncating Variants in APOB, Lower Low-Density Lipoprotein Cholesterol, and Protection Against Coronary Heart Disease.
    Peloso GM; Nomura A; Khera AV; Chaffin M; Won HH; Ardissino D; Danesh J; Schunkert H; Wilson JG; Samani N; Erdmann J; McPherson R; Watkins H; Saleheen D; McCarthy S; Teslovich TM; Leader JB; Lester Kirchner H; Marrugat J; Nohara A; Kawashiri MA; Tada H; Dewey FE; Carey DJ; Baras A; Kathiresan S
    Circ Genom Precis Med; 2019 May; 12(5):e002376. PubMed ID: 30939045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.